Short-term safety and adverse event risk profiles for SARS-CoV-2 booster vaccine doses in Australian adults: a survey study Read more about Short-term safety and adverse event risk profiles for SARS-CoV-2 booster vaccine doses in Australian adults: a survey study11 views
Surveillance of adverse events following immunisation in Australia, 2023 Read more about Surveillance of adverse events following immunisation in Australia, 20232 views
Surveillance of adverse events following immunisation in Australia annual report, COVID-19 vaccines, 2022 Read more about Surveillance of adverse events following immunisation in Australia annual report, COVID-19 vaccines, 20225 views
Surveillance of adverse events following immunisation in Australia annual report, 2022. Read more about Surveillance of adverse events following immunisation in Australia annual report, 2022.10 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-20229 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022162 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-202223 views
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study Read more about Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study14 views
Surveillance of adverse events following immunisation in Australia, 2022 Submitted by scott.mair@hea… on Thu, 08/05/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, 202273 views
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial Read more about Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial28 views
